Tractament antiviral de l'hepatitis C crònica a l'any 2019, 2020 i 2021: informe d'avaluació de resultats
Abstract
Minority diseases pose a major challenge to the health system, as they often have a genetic origin, can affect many organs, be serious, pose a vital threat, or be chronically debilitating. Their diagnosis is difficult, they have few therapeutic options and due to their characteristics, they require a multidisciplinary approach.
Keywords
Antiviral drugs; Chronic infection; Economic expenditure
Bibliographic citation
Programa d'Harmonització Farmacoterapèutica. Tractament antiviral de l'hepatitis C crònica a l'any 2019, 2020 i 2021: informe d'avaluació de resultats. Barcelona: Servei Català de la Salut; 2022.
Audience
Professionals
Use this identifier for quote and/or link this document
https://hdl.handle.net/11351/7123This item appears in following collections
The following license files are associated with this item: